Pharma Is Out of Favor. 5 Drug Stocks With Room to Grow.


Most drug stocks have been out of favor in 2023.

Pfizer was down 43.4% as of the market close Monday, while

Johnson & Johnson is down 16.4%. Despite Eli Lilly’s monster 66.8% gain on the year, amid investor frenzy over its

weight-loss drugs, the S&P 500 Pharmaceuticals index is down 2.3%.

Source link

Related Articles

Back to top button